<DOC>
	<DOC>NCT00149422</DOC>
	<brief_summary>The purpose of this study is to determine whether NT-proBNP guided treatment of chronic congestive heart failure will reduce heart failure related morbidity and mortality compared to therapy guided by standard clinical judgement.</brief_summary>
	<brief_title>Effect of NT-proBNP Guided Treatment of Chronic Heart Failure</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Admission because of congestive heart failure Elevated NTproBNP levels on admission Lifethreatening cardiac arrhythmias Urgent intervention Severe lung disease Presence of life threatening disease Signed informed consent for other study Mental or physical status not allowing written informed consent. Unwillingness to give informed consent Patients undergoing haemodialysis or continuous ambulatory peritoneal dialysis (CAPD)</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2008</verification_date>
	<keyword>NT-proBNP</keyword>
</DOC>